about
Germline genetic variants disturbing the Let-7/LIN28 double-negative feedback loop alter breast cancer susceptibilityIn search of low-frequency and rare variants affecting complex traitsSusceptibility pathways in Fanconi's anemia and breast cancerA Review of the Clinical Implications of Breast Cancer BiologyComprehensive splicing functional analysis of DNA variants of the BRCA2 gene by hybrid minigenesThe genetics of breast cancer risk in the post-genome era: thoughts on study design to move past BRCA and towards clinical relevanceCancer evolution and individual susceptibilityPALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSEvolution of the cancer genomeThe emergence of human-evolutionary medical genomicsRare, evolutionarily unlikely missense substitutions in CHEK2 contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening studyCommon and rare variants in multifactorial susceptibility to common diseasesContralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: a WECARE study report.Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study.Exome sequencing of germline DNA from non-BRCA1/2 familial breast cancer cases selected on the basis of aCGH tumor profiling.Asf1b, the necessary Asf1 isoform for proliferation, is predictive of outcome in breast cancer.The 'common disease-common variant' hypothesis and familial risks.An Integrative Genomics Approach for Associating GWAS Information with Triple-Negative Breast Cancer.Variations in the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2 French Canadian families with high risk of breast cancerLow-risk susceptibility alleles in 40 human breast cancer cell linesDetecting rare variants for complex traits using family and unrelated data.Mutation analysis of the AATF gene in breast cancer families.Prevalence of the variant allele rs61764370 T>G in the 3'UTR of KRAS among Dutch BRCA1, BRCA2 and non-BRCA1/BRCA2 breast cancer families.Genome instability in blood cells of a BRCA1+ breast cancer family.Beyond genome-wide association studies: genetic heterogeneity and individual predisposition to cancer.A rare FANCA gene variation as a breast cancer susceptibility allele in an Iranian population.A novel adaptive method for the analysis of next-generation sequencing data to detect complex trait associations with rare variants due to gene main effects and interactions.An alternative model for (breast) cancer predisposition.Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility.Replication of genome-wide discovered breast cancer risk loci in the Cypriot population.Kernel-machine testing coupled with a rank-truncation method for genetic pathway analysis.Mutation screening of the MERIT40 gene encoding a novel BRCA1 and RAP80 interacting protein in breast cancer familiesFamily-specific, novel, deleterious germline variants provide a rich resource to identify genetic predispositions for BRCAx familial breast cancer.Mutations in BRCA2 and taxane resistance in prostate cancerDetecting association of rare and common variants based on cross-validation prediction error.Type II transmembrane serine protease gene variants associate with breast cancer.Design considerations for massively parallel sequencing studies of complex human diseaseA rare variant association test based on combinations of single-variant tests.Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions.Breast cancer susceptibility: current knowledge and implications for genetic counselling
P2860
Q21144942-D00B3C87-B21D-49B5-9C80-D4F6687D9F36Q24618492-ABA5B6E2-8A14-4B64-A70F-3EF2FF0F3FAFQ24628760-BD9BFD9A-4A09-4A31-9F15-C5E07556E290Q26744288-9354BF2C-0433-4E6D-8A2A-6B6446576003Q27499325-36ABB95D-CDC0-476D-AD8A-B420A7BF979AQ28074414-29EA1B43-12BA-46DA-836B-33BD7EBB6AC1Q28389946-D23CD2BE-E49A-4CC8-93B6-AD23AD8603F5Q28584533-19117E4B-1BB2-4B39-8990-EF5C790A9DF9Q28678232-BD7777C9-8DBA-4D8A-ABDB-5488984C2DE9Q28729955-C0D8545D-B90D-4F50-B02E-AF4ED1B71D1FQ28743906-B74BE813-72DC-4B2A-A8BF-AB766A87D412Q29616282-93016FCB-D060-49D0-88FC-47EAFF61ACA0Q30410984-AFBA6A25-328B-4421-B340-AA27D642C0DBQ30433040-1ACF1A2F-B27D-4D01-8B03-33A315186557Q30458477-DDDDB27E-0EAE-4C68-98DF-8F28048F691FQ33292388-AB28769A-76F4-46A3-8622-49B7128D96FFQ33344459-16AF8464-A612-4A3D-B9BC-6009D02B56C1Q33355327-87CE23F2-F6CC-4CF3-92B0-0B98D077923EQ33467074-E96F771C-7C6F-432C-85FA-FB163DAEFFBBQ33483075-7758A5A4-9C8B-49F4-BE4D-59A9AA5DD43DQ33511799-B2F737B6-7AE2-4544-B944-74EE42141715Q33520087-0D5B9BB9-C3B1-41FB-83AD-93B7A0F593A9Q33646928-01270B81-A475-4721-A821-7654C19FFD80Q33651926-4187F7DC-6066-43DF-996E-40DD32D4BB3DQ33679037-8E8D8ABF-8DEE-4405-9CC5-E91A8D036929Q33702054-CBBCF7AB-ED64-48E2-819B-1785BCA57DE7Q33728642-69C68B27-A0FE-4D90-A911-891597972A4CQ33767039-E29BD670-D50A-49DF-B557-75F7B8663841Q33782791-1CD963CC-2B6E-4B7A-97F4-10D3C8BFA07DQ33787026-E2602DD3-1D57-44B4-803E-49B4747C2211Q33814014-929E25FF-0456-4BC2-8454-8850DF67E419Q33824592-9C64E97C-2871-40DE-8D4E-BC9EAE8719B1Q33850753-5CE23610-9E91-470F-B715-340DD52E85F2Q33870601-F16E305B-F78A-42DB-AD45-EC42AB25FAE3Q33887770-B16DDF8D-A74D-4833-9247-2D8C9795CDE1Q33910850-8FF291A3-231F-42FF-B691-DC693B92B999Q33995664-3D5E1CEC-4CD1-4025-9488-A77E8D9F519EQ34021946-D3A09050-7ED3-43B1-B675-79082FA59B1BQ34038964-56CC9472-F740-47B4-969C-5CD8D95D79D1Q34161642-A65C6D8A-4A06-4F26-B4EC-E1708B27CDEC
P2860
description
im Januar 2008 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2008
@uk
name
The emerging landscape of breast cancer susceptibility
@en
The emerging landscape of breast cancer susceptibility
@nl
type
label
The emerging landscape of breast cancer susceptibility
@en
The emerging landscape of breast cancer susceptibility
@nl
prefLabel
The emerging landscape of breast cancer susceptibility
@en
The emerging landscape of breast cancer susceptibility
@nl
P356
P1433
P1476
The emerging landscape of breast cancer susceptibility
@en
P2888
P356
10.1038/NG.2007.53
P407
P577
2008-01-01T00:00:00Z